HOME >> MEDICINE >> NEWS
Endocrine Society calls for clinical guidelines on androgens for women

Chevy Chase, MD The Endocrine Society, which represents more than 12,000 endocrinologists who are specially trained to diagnose, treat and conduct basic and clinical research on complex hormonal disorders, today called for new clinical guidelines on the use of androgens in women/female sexual dysfunction. The organization also notes that additional research into androgens and women as well sexual dysfunction in women will help doctors and patients better understand how to diagnose and effectively treat this condition. This announcement comes as Intrinsa--a testosterone skin patch for women--is reviewed by the Food and Drug Administration as a treatment for a specific population of women who suffer from sexual dysfunction.

"Because of the growing recognition of female sexual dysfunction as well as the increase in women seeking treatment, The Endocrine Society is in the early stages of preparing clinical guidelines for the care of these patients," announced Endocrine Society President, Anthony Means, Ph.D. "As new treatments come available, we want to make sure that physicians understand how and when to use them to treat patients. We plan to release our clinical guidelines in 2005."

--Female Sexual Dysfunction--

Female sexual dysfunction affects over 40 percent of women in the United States, according to a 1999 study from The Journal of the American Medical Association. As experts evaluate women with potential sexual interest disorders, there is a growing amount of information to guide them in how to understand, diagnose and treat these problems. Androgens -- hormones like testosterone that produce male characteristics -- are known to be involved in women's arousability, response and intensity and ease of orgasm, as well as in initial spontaneous desire. Androgens are also involved in the active neurovascular smooth muscle response of swelling and increased lubrication and likely affect genital sexual sensitivity. The testoster
'"/>


2-Dec-2004


Page: 1 2 3

Related medicine news :

1. AACC and The Endocrine Society partner to promote patient education
2. ENDO 2005 - The Endocrine Societys 87th annual meeting
3. Endocrine Society and Hormone Foundation call for increased research
4. ENDO 2004, The 86th Annual Meeting of The Endocrine Society
5. Endocrine Society hosts thyroid disease audioconference
6. Endocrine Society to host audioconference on testosterone therapy for elderly men
7. The Endocrine Society responds to Institute of Medicine report on testosterone therapy for older men
8. The Gerontological Society of America announces Hartford Fellowship recipients
9. The European Society of Cardiology launches Women at Heart
10. American Thoracic Society Journal news tips for March 2005 (second issue)
11. American Thoracic Society Journal news tips for March 2005 (first issue)

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... ... 30, 2017 , ... According to the American Society of Plastic Surgeons (ASPS), ... the top 5 most popular minimally-invasive cosmetic procedures in the country. With summer close, ... over the next 8-10 weeks. For anyone considering a hair removal procedure, there are ...
(Date:3/30/2017)... ... March 30, 2017 , ... AudioEducator, a ... “ Preventing Hospital Readmissions Through Discharge Planning ” with noted expert Sue Dill ... This conference discusses strategies to prevent readmissions in light of the most recent ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... women’s professional squash, announced it has enlisted New York City-based sports and entertainment ... will develop and procure sponsorship opportunities for the Professional Squash Association (PSA), which ...
(Date:3/29/2017)... Petersburg, FL (PRWEB) , ... March 30, 2017 , ... ... called the "Spice of Life" or "Wonder Spice", it has been used for thousands ... use in the East," says Heshelow, author of " Turmeric: How to Use it ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... provides insight into the challenges employers face in trying to balance both short-term ... employee benefits programs? Adding to the growing complexity, companies are finding that ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... 2017  Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, ... Phase 2b dose-ranging study of AKCEA-APO(a)-L Rx in ... of the study is to determine the dose level ... a planned Phase 3 cardiovascular outcome study. ... collaboration with Novartis to develop and commercialize drugs to ...
(Date:3/29/2017)... QUEBEC CITY , March 29, 2017 /PRNewswire/ ... Food and Drug Administration (FDA) 510(k) clearance for ... launch of this truly personalized orthopaedic restoration. Bodycad ... clearance for a joint reconstruction implant system. ... designed to optimize personalized restoration of the patient,s ...
(Date:3/29/2017)... 29, 2017 Avelas Biosciences, Inc., a clinical stage oncology-focused ... today announced that Carmine N. Stengone , president and chief ... Needham & Company 16 th Annual Healthcare Conference on Wednesday, ... the Westin Grand Central Hotel in New York City ... ...
Breaking Medicine Technology:
Cached News: